BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20029944)

  • 21. [Role of gene polymorphisms of phase II of xenobiotic biotransformation from glutathione-S-transferase and N-acetyltransferase families in susceptibility to lung cancer among Mayak workers].
    Rusinova GG; Azizova TV; Viazovskaia NS; Glazkova IV; Gur'ianov MIu; Osovets SV
    Radiats Biol Radioecol; 2014; 54(4):350-9. PubMed ID: 25775823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.
    Sweeney C; Nazar-Stewart V; Stapleton PL; Eaton DL; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):527-33. PubMed ID: 12814998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of GSTM1, GSTT1, GSTP1, NAT1, NAT2, EPHX1, MTR and MTHFR polymorphism on chromosomal aberration frequencies in human lymphocytes.
    Skjelbred CF; Svendsen M; Haugan V; Eek AK; Clausen KO; Kure EH; Tuimala JT; Svendsen MV; Norppa H; Hansteen IL
    Carcinogenesis; 2011 Mar; 32(3):399-405. PubMed ID: 21097530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan.
    Wu MS; Chen CJ; Lin MT; Wang HP; Shun CT; Sheu JC; Lin JT
    Int J Colorectal Dis; 2002 Sep; 17(5):338-43. PubMed ID: 12172927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of GSTM1, GSTT1, GSTP1 and CYP2E1 single nucleotide polymorphisms with colorectal cancer in Iran.
    Ebrahimkhani S; Asgharian AM; Nourinaier B; Ebrahimkhani K; Vali N; Abbasi F; Zali MR
    Pathol Oncol Res; 2012 Jul; 18(3):651-6. PubMed ID: 22228187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic polymorphisms in cytochrome P450s, GSTs, NATs, alcohol consumption and risk of non-Hodgkin lymphoma.
    Li Y; Zheng T; Kilfoy BA; Lan Q; Holford T; Han X; Zhao P; Dai M; Leaderer B; Rothman N; Zhang Y
    Am J Hematol; 2010 Mar; 85(3):213-5. PubMed ID: 20131310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms of glutathione S-transferase mu 1, theta 1, and pi 1 genes and prognosis in Hodgkin lymphoma.
    Lourenço GJ; Lorand-Metze I; Delamain MT; Miranda EC; Kameo R; Metze K; Lima CS
    Leuk Lymphoma; 2010 Dec; 51(12):2215-21. PubMed ID: 20977336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detoxication gene polymorphism and susceptibility to sporadic motor neuron disease in Russian population].
    Skvortsova VI; Slominskiĭ PA; Shadrina MI; Levitskiĭ GN; Levitskaia NI; Alekhin AV; Zherebtsova AL; Serdiuk AV; Limborskaia SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(1):4-13. PubMed ID: 16459354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma: a population-based case-control study.
    Chiu BC; Kolar C; Gapstur SM; Lawson T; Anderson JR; Weisenburger DD
    Br J Haematol; 2005 Mar; 128(5):610-5. PubMed ID: 15725081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
    Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
    Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphisms of phase II metabolic enzymes and lung cancer susceptibility in a population of Central South China.
    Chen HC; Cao YF; Hu WX; Liu XF; Liu QX; Zhang J; Liu J
    Dis Markers; 2006; 22(3):141-52. PubMed ID: 16788248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma.
    Yri OE; Ekstrøm PO; Hilden V; Gaudernack G; Liestøl K; Smeland EB; Holte H
    Leuk Lymphoma; 2012 Oct; 53(10):1934-44. PubMed ID: 22475179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk.
    Kerridge I; Lincz L; Scorgie F; Hickey D; Granter N; Spencer A
    Br J Haematol; 2002 Aug; 118(2):477-81. PubMed ID: 12139735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response.
    Rostami G; Assad D; Ghadyani F; Hamid M; Karami A; Jalaeikhoo H; Kalahroodi RA
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00717. PubMed ID: 31111691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity.
    Singla N; Gupta D; Birbian N; Singh J
    Tuberculosis (Edinb); 2014 May; 94(3):293-8. PubMed ID: 24637014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutathione S-transferase polymorphisms and survival in primary malignant glioma.
    Okcu MF; Selvan M; Wang LE; Stout L; Erana R; Airewele G; Adatto P; Hess K; Ali-Osman F; Groves M; Yung AW; Levin VA; Wei Q; Bondy M
    Clin Cancer Res; 2004 Apr; 10(8):2618-25. PubMed ID: 15102663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population.
    Rossini A; Rapozo DC; Soares Lima SC; Guimarães DP; Ferreira MA; Teixeira R; Kruel CD; Barros SG; Andreollo NA; Acatauassú R; Matos HJ; Albano RM; Pinto LF
    Carcinogenesis; 2007 Dec; 28(12):2537-42. PubMed ID: 17916905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of genetic polymorphisms of
    Yang S; Hwang SJ; Park JY; Chung EK; Lee JI
    BMJ Open; 2019 Aug; 9(8):e027940. PubMed ID: 31375612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors.
    De Roos AJ; Rothman N; Inskip PD; Linet MS; Shapiro WR; Selker RG; Fine HA; Black PM; Pittman GS; Bell DA
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):14-22. PubMed ID: 12540498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic polymorphism of drug metabolizing enzymes (CYP2E1, GSTP1) and susceptibility to bladder cancer in North India.
    Mittal RD; Srivastava DS; A M; B M
    Asian Pac J Cancer Prev; 2005; 6(1):6-9. PubMed ID: 15780023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.